Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · IEX Real-Time Price · USD
4.020
-0.030 (-0.74%)
At close: Jul 2, 2024, 3:59 PM
4.010
-0.010 (-0.25%)
After-hours: Jul 2, 2024, 7:46 PM EDT
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $4.96 million as of July 2, 2024. Its market cap has decreased by -29.18% in one year.
Market Cap
4.96M
Enterprise Value
-23.31M
1-Year Change
-29.18%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since December 9, 2020, Synaptogenix's market cap has decreased from $14.70M to $4.96M, a decrease of -66.27%. That is a compound annual growth rate of -26.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 5.00M | -9.09% |
Dec 29, 2023 | 5.50M | -30.38% |
Dec 30, 2022 | 7.90M | -86.09% |
Dec 31, 2021 | 56.80M | 170.48% |
Dec 31, 2020 | 21.00M | 42.86% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ainos | 5.29M |
Pasithea Therapeutics | 5.28M |
Creative Medical Technology Holdings | 5.19M |
TFF Pharmaceuticals | 5.14M |
Titan Pharmaceuticals | 5.09M |
Venus Concept | 4.97M |
Leafly Holdings | 4.95M |
Hoth Therapeutics | 4.87M |